American Medical Technologies Inc.

American Medical Technologies Inc.

ADLI
American Medical Technologies Inc.US flagOther OTC
0.00
USD
- -
- -
1,031.00Market Cap
1995 Y
1996 Y
1997 Y
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
TTM
Revenue per Share
3.48
3.95
3.13
3.89
3.09
2.74
2.1
1.26
0.41
0.39
0.26
0.34
0.37
0.26
Basic EPS, GAAP
-0.34
1.08
0.52
1.21
0.05
-2.53
-0.57
-0.98
0.01
-0.01
-0.19
-0.17
-0.11
0.02
Free Cash Flow per Basic Share
0.03
-0.04
0.23
-0.49
0.23
0.14
-0.04
-0.12
-0.08
-0.59
-0.19
-0.18
-0.04
-0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.02
- -
- -
- -
- -
Book Value per Share
-7.74
-4.58
-2.91
-1.43
-1.28
-4.02
-4.76
-5.6
-5.46
-6.91
-5.14
-5.31
-5.1
-4.3
Tangible Book Value per Share
-0.84
1.18
1.37
2.36
2.31
1.32
0.84
-0.01
0.47
0.36
0.06
-0.16
-0.16
-0.11
Basic Weighted Avg Shares
4
5
7
7
8
7
7
7
7
6
8
8
9
10
Sales/Revenue/Turnover
13
20
22
28
24
20
15
9
3
2
2
3
3
3
Operating Margin (%)
-11.28
16.59
15.21
13.78
-1.16
-67.43
-26.81
-69.44
-131.37
-79.19
-76.26
-60.48
-36.48
-18.15
Depreciation Expense
1
1
1
2
2
2
1
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
6
4
9
- -
-18
-4
-7
- -
- -
-2
-1
-1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
61.14
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-9.77
27.32
16.59
31.1
1.62
-92.47
-27.08
-77.53
1.79
1.31
-71.47
-50.01
-29.04
7.34
Working Capital
-2
5
8
18
17
10
4
-2
-2
2
- -
-1
-1
-1
LT Debt
1
- -
- -
6
5
2
- -
- -
1
1
1
- -
- -
- -
Total Equity
2
17
20
32
32
13
9
2
3
2
1
-1
-1
- -
Return on Invested Capital (%)
- -
- -
- -
- -
-0.29
- -
- -
- -
-93.58
-51.57
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'08
Jun'08
Sep'08
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
1
1
1

Working Capital

FRC

in mil. unless spec.
Mar'08
Jun'08
Sep'08
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
1
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-45.36%
-68.06%
-40.11%
Free Cash Flow
-10.7%
60.86%
-74.32%
Net Income, GAAP
-1,028.2%
-1,106.02%
-32.93%
Sales/Revenue/Turnover
-11.88%
-10.52%
15.49%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
1
1
1
3
2007
1
1
1
1
3
2008
1
1
1
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
-0.11
-0.03
-0.01
- -
-0.17
2007
-0.08
-0.01
-0.04
- -
-0.11
2008
- -
0.02
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Roger A. Dartt
Full Time Employees
12
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
5655 Bear Lane Corpus Christi TX United States of America 78405
IPO Date
Oct 31, 1994
Business
American Medical Technologies Inc operates as a medical device manufacturing company specializing in the design, development, and production of innovative medical technologies and products for healthcare applications. The company's core offerings include advanced medical devices and equipment targeting multiple therapeutic areas and clinical needs, emphasizing cutting-edge technology and custom solutions for hospitals, clinics, and healthcare providers primarily in the United States and international markets. Founded in 1995 and headquartered in Bridgeport, Connecticut, American Medical Technologies services a broad base of medical facilities with its portfolio of diagnostic and therapeutic devices, surgical instruments, and patient monitoring systems. In recent years, the company has focused on strategic expansion through the launch of new medical device lines and the formation of partnerships aimed at integrating artificial intelligence and advanced data analytics into its product offerings to enhance clinical outcomes and operational efficiencies. In 2024 and 2025, American Medical Technologies secured significant partnerships with major healthcare technology firms to accelerate innovation in diagnostic accuracy and remote patient monitoring, reflecting a shift toward digital health integration. The company also completed a notable acquisition of a smaller medical device startup specializing in AI-driven diagnostics, reinforcing its commitment to leveraging tech-enabled solutions as a growth driver. As part of its latest operational developments, American Medical Technologies has invested heavily in expanding its manufacturing capacity and capabilities with advanced automation and quality control measures to meet increasing global demand. These efforts coincide with enhanced regulatory compliance initiatives and market entry strategies for Europe and Asia, aimed at broadening its geographic footprint and accessing new revenue streams in emerging healthcare markets. The company's continuous focus on research and development, along with strategic alliances and acquisitions, positions it as a competitive player in the evolving medtech landscape.